![Amicus Therapeutics Inc](/common/images/company/N_FOLD.png)
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It... Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.01 | -0.100908173562 | 9.91 | 10.05 | 9.68 | 2152551 | 9.88354728 | CS |
4 | -0.135 | -1.34529147982 | 10.035 | 10.98 | 9.555 | 2420393 | 10.05060016 | CS |
12 | -1.17 | -10.5691056911 | 11.07 | 11.07 | 9.02 | 2570358 | 10.04812446 | CS |
26 | -3.42 | -25.6756756757 | 13.32 | 14.09 | 9.02 | 2826298 | 11.52862464 | CS |
52 | -2.43 | -19.7080291971 | 12.33 | 14.57 | 9.02 | 2731208 | 11.86572968 | CS |
156 | 0.24 | 2.48447204969 | 9.66 | 14.57 | 5.91 | 2699217 | 10.94079252 | CS |
260 | -2.61 | -20.8633093525 | 12.51 | 25.39 | 5.91 | 2728088 | 11.52730878 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.